In conclusion, our findings suggested that IL-17A was able to promote the migration and invasiveness of GC cells by activating NF-κB pathway, which subsequently upregulated the expressions of MMP-2 and MMP-9 and thereby affected migration and invasiveness of GC cells. The gene discussed is IL17A; the disease is gastric cancer.